Find your path to Lucio
375 people in our graph can introduce you to Lucio.
Sign up to see every warm intro you have to Lucio
- Paths you didn't know you had: your email and LinkedIn already hold routes to Lucio. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
Experience
- T1D FundSr Managing Directorcurrent2025 — presentБостон, MA
- Amana Global PartnersSenior Investment Advisorcurrent2023 — present
- COUR PharmaBoard Observercurrent2025 — present
- Leaps by BayerHead of Venture Investments2021 — 2025Кембридж, MA
- Leaps by BayerSr Director of Venture Investments2017 — 2021Boston, Massachusetts
- Soufflé TherapeuticsBoard Member2023 — 2025
- Paratus SciencesBoard Member2022 — 2025Cambridge, Massachusetts, United States
- CellinoBoard Member2022 — 2025Cambridge, Massachusetts, United States
- Mozart Therapeutics, IncBoard Member2021 — 2025Seattle, Washington, United States
- Deka Biosciences, IncBoard Member2021 — 2025Germantown, Maryland, United States
- eGenesis, Inc.Board Member2019 — 2025Cambridge, Massachusetts
- Immunitas TherapeuticsBoard Member2019 — 2025Cambridge, Massachusetts
- Capstan TherapeuticsBoard Observer2023 — 2025Boston, Massachusetts, United States
- NextPoint Therapeutics, Inc.Board Observer2022 — 2025Cambridge, Massachusetts, United States
- Boundless BioBoard Observer2023 — 2025San Diego, California, United States
- Axxam S.p.ABoard Member2019 — 2022
- MetagenomiBoard Observer2020 — 2022
- Pyxis OncologyBoard Member2019 — 2021Cambridge, Massachusetts
- Silence Therapeutics plcHead of Business Development2015 — 2017London, England, United Kingdom
- Silence Therapeutics plcScientific Officer Translational Medicine2014 — 2015London
- Imperial College LondonCardiovascular Scientist2011 — 2014Londra, Regno Unito
Skills & more
Cell Biology23Biotechnology22Cell Culture9Genetics8Pharmaceutical Industry9Biochemistry6Pharmacokinetics5Lifesciences5Pharmacology4Drug development4Ricerca4Scienza4
+12 more
GeneticaIndustria farmaceuticaBiochimicaBiotecnologiaBiologia molecolareScienze naturaliIn vitroR&DABPI code of practiceReal TimeStrategiaBloombergLanguages Inglese · Italiano · Portoguese · Spanish
From Lucio's professional profile.
Investments
Per curated public sources.
Colleagues at JDRF T1D Fund
Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures
Network2
Investors connected to Lucio in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Lucio Iannone?
- Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
- Where does Lucio Iannone work?
- Lucio Iannone is Managing Director at JDRF T1D Fund.
- What companies has Lucio Iannone invested in?
- Investments tracked here include Caspian Therapeutics, eGenesis, Immunitas Therapeutics, Mozart Therapeutics, Paratus Sciences.
- Where did Lucio Iannone go to school?
- Lucio Iannone studied at Imperial College London (Doctor of Philosophy (Ph.D.), Medicine); Università degli Studi di Napoli Federico II (Bachelor's degree, Biotechnology).
Same school
Also attended Imperial College London891
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 885 more
Also attended Università degli Studi di Napoli Federico II39
Fabio CampanileSwitzerland Board Member at MassChallenge MexicoGiuseppe JandoliInvestment Analyst at Apex CapitalLuca QuagliataVenture Partner at XGEN VentureLuca CaralviVenture Partner at VentureWave Capital Ltd.Andrea MormonePrincipal at Tages Capital SGR S.p.A.Pasquale RolandoInvestor at Nuova Energia Holding S.p.A.
+ 33 more
Shared employers
Also worked at COUR Pharma3
Also worked at Leaps by Bayer8
Julie YangInvestor at Third Rock VenturesBrendan KellyPrincipal at Lightstone VenturesLee CooperManaging Director at Delos CapitalFabio PucciPartner at Arkin CapitalPaimun AminiInvestor at Leaps by BayerRakhshita DharInvestor at Leaps by Bayer
+ 2 more
Also worked at Cellino8
Tobi CokerDeal Partner at Felicis VenturesFrancisco GimenezInvestment Team at 8VCChris GibsonPortfolio Director, Private Equity at Bridges Fund Management Ltd.Ananya ZutshiFounder at Guardian BioNabiha SaklayenCo-Founder & CEO at Cellino BioStan WangMD, PhD at Thymmune
+ 2 more
Also worked at Boundless Bio9
Jakob LovenPartner at Nextech InvestFabio PucciPartner at Arkin CapitalKeith LendenVenture Partner at ARCH Venture PartnersJonathan LimVenture Partner at ARCH Venture PartnersZachary D. HornbyExecutive Officer, Director at Boundless BioJames LeeVP, Business Development at Valora Therapeutics
+ 3 more

























































